Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, October 17, 2023
P95 BV, a portfolio company of Ampersand Capital Partners and leading provider of clinical and observational services to vaccine developers, has signed an agreement to merge OnQ Research into P95.
read more
Wednesday, January 10, 2018
Adimab announced a multi-target partnership with Boehringer Ingelheim.
read more
Monday, February 26, 2018
Minerva Biotechnologies announced a European distribution agreement with CellSystems GmbH a European life science supplier, for AlphaSTEM Naïve Stem Cell Culture System.
read more
Don Kania, Ph.D., has been appointed to the Board of Directors of Aldevron, a global provider of plasmid DNA manufacturing, protein production and antibody discovery services.
read more
Pharmaceutical Product Development, LLC (PPD) today announced the addition of Bhooshi De Silva as senior vice president of corporate development and strategy to its executive leadership team. De Silva will focus on key strategic initiatives vital to ...
read more
Tuesday, December 29, 2015
Biotechnology companies continue to forge ahead with advancing clinical trials and development of next-generation treatments for rare diseases through new orphan drug designations and cutting edge drug delivery products.
read more
Cmed Clinical Services, an eClinical technology-led CRO, announced today the appointment of Graham Belgrave as Chief Operations Officer.
read more
Brammer Biopharmaceuticals has announced its merger with Florida Biologix to create a cell and gene therapy biologics contract development and manufacturing organization (CDMO). The merged company, Brammer Bio, will combine deep technical expertise ...
read more
EpiVax, Inc. announces participation in a new project with Intravacc, funded by CEPI (Coalition for Epidemic Preparedness Innovations), to develop universal vaccines for betacoronaviruses, including SARS-CoV-2. EpiVax will be carrying out the vaccine...
read more
Anbio, a leading provider of innovative diagnostic Solutions, presents the Anbio LAMP Solution, an innovative point-of-care Solution designed for easy-to-use but elegantly sophisticated qualitative diagnostics.
read more
The Menarini Group and Radius Health announced the companies have entered into an exclusive global license agreement for development and commercialization of elacestrant.
read more
Wednesday, September 16, 2020
The FDA has issued a temporary guidance, “Resuming Normal Drug and Biologics Manufacturing Operations During the COVID-19 Public Health Emergency.”
read more
Aptamer Group, the developer of diagnostic and therapeutic Optimer™ reagents, announced that it has signed an agreement with the multinational pharmaceutical and biopharmaceutical company Takeda Pharmaceutical Company Limited (“Takeda”).
read more
Friday, November 05, 2021
McKesson Corporation has opened a new pharmaceutical distribution center in Holt, Michigan, seven miles south of Lansing.
read more
Charles River Laboratories announced the appointment of Dr. Martin Mackay, Executive Vice President, Alexion Pharmaceuticals to its Board of Directors.
read more